Britain France city Sanofi, France World Europe Britain France city Sanofi, France

France's Sanofi halts work on anti-Covid vaccine

Reading now: 696
www.rte.ie

France's pharmaceutical giant Sanofi, which has lagged rivals in producing new generation Covid-19 vaccines, has said it has decided to halt development of an mRNA candidate and focus on another vaccine against coronavirus.

Despite positive results at phase one and two trials, the candidate will not go to the third and final phase, Sanofi said, as they believed it would arrive too late to market with 12 billion anti-Covid doses already due to be produced by the end of the year.

Results from phase three trials of the other vaccine, developed with Britain's GlaxoSmithKline, are expected before the end of 2021.

The firms are combining a Sanofi-developed antigen, which stimulates the production of germ-killing antibodies, with GSK's adjuvant

Read more on rte.ie
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA